News
Seoul: Celltrion, a leading South Korean biopharmaceutical company, on Thursday said its business will remain largely ...
22h
Yonhap News Agency on MSNCelltrion expects minimal impact from Trump's drug pricing orderCelltrion Inc., a leading South Korean biopharmaceutical company, said Thursday its business will remain largely unaffected ...
Pharmaceutical tariffs, as proposed by President Donald Trump, aim to create manufacturing jobs in the United States, limit ...
Local pharmacists said current tariff policies will make drugs more expensive and harder to find for consumers.
If President Trump's threat to impose tariffs on pharmaceutical products goes through, it would have severe consequences for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results